Close



Mar 6, 2024 07:04AM
Mar 6, 2024 07:02AM
Feb 28, 2024 07:00AM
Jan 4, 2024 07:04AM
Jan 4, 2024 07:00AM
Nov 9, 2023 07:05AM
Nov 9, 2023 07:00AM Xeris Biopharma Reports Third Quarter 2023 Financial Results
Oct 16, 2023 07:01AM
Oct 16, 2023 07:00AM
Aug 8, 2023 07:08AM
Aug 8, 2023 07:00AM
Aug 1, 2023 07:00AM
May 9, 2023 08:04AM
May 9, 2023 07:00AM Xeris Biopharma Reports First Quarter 2023 Financial Results
May 2, 2023 07:00AM
Mar 8, 2023 06:30AM
Mar 8, 2023 06:00AM
Feb 23, 2023 07:00AM
Jan 5, 2023 07:04AM
Jan 5, 2023 07:00AM
Nov 9, 2022 07:17AM Xeris Pharmaceuticals Inc. (XERS) Tops Q3 EPS by 3c
Nov 9, 2022 07:00AM
Nov 2, 2022 07:00AM
Aug 10, 2022 07:06AM
Aug 10, 2022 07:00AM
Aug 3, 2022 07:30AM
May 11, 2022 07:00AM
May 4, 2022 08:00AM Xeris Biopharma to Report First Quarter 2022 Financial Results on May 11, 2022
Mar 10, 2022 07:02AM
Mar 10, 2022 07:00AM
Mar 4, 2022 07:00AM
Jan 18, 2022 07:04AM
Jan 18, 2022 07:00AM
Nov 10, 2021 07:22AM
Nov 10, 2021 07:00AM Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights
Nov 2, 2021 07:30AM
Oct 5, 2021 04:01PM
Sep 8, 2021 04:04PM
Sep 8, 2021 04:01PM
Aug 31, 2021 07:30AM
Aug 30, 2021 07:31AM
Aug 30, 2021 07:30AM Xeris Pharmaceuticals Announces Leading Independent Proxy Advisory Firm, ISS, Recommends Xeris Stockholders Vote “FOR” the Transaction With Strongbridge Biopharma
Aug 30, 2021 07:30AM
Aug 5, 2021 07:58AM
Aug 5, 2021 07:00AM
Jul 29, 2021 04:05PM
Jul 29, 2021 08:30AM
May 24, 2021 04:58PM
May 24, 2021 07:00AM Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases
May 24, 2021 06:56AM

976,651 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All